Watchman Group, Inc. Amgen Inc Transaction History

Watchman Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $31,283 - $36,992	-146 Reduced 1.15%	12,531 $2.78 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $6,773 - $8,256	-30 Reduced 0.24%	12,677 $3.06 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $1,145 - $1,455	5 Added 0.04%	12,707 $3.34 Million
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $15,263 - $17,214	-68 Reduced 0.53%	12,702 $2.86 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $20,533 - $22,849	-89 Reduced 0.69%	12,770 $3.11 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $119,063 - $131,715	543 Added 4.41%	12,859 $3.11 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $90,689 - $103,785	456 Added 3.84%	12,316 $2.77 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $31,840 - $37,305	-150 Reduced 1.25%	11,860 $2.52 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $700 - $777	3 Added 0.02%	12,010 $2.93 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $114,949 - $133,954	518 Added 4.51%	12,007 $2.99 Million
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $35,919 - $42,773	-166 Reduced 1.42%	11,489 $2.64 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $77,434 - $86,113	-330 Reduced 2.75%	11,655 $2.96 Million
Q2 2020 Jul 07, 2020	SELL	$197.81 - $242.74 $34,418 - $42,236	-174 Reduced 1.43%	11,985 $2.83 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $14,943 - $19,819	-82 Reduced 0.67%	12,159 $2.47 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $2.32 Million - $2.98 Million	12,241 New	12,241 $2.95 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Watchman Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Watchman Group, Inc. with notifications on news.